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Abstract
Purpose The objective of this study was to determine the
impact of family income and sickle cell disease on the
health-related quality of life (HRQL) of children.
Methods This was a cross-sectional study of children
with and without sickle cell disease. Participants completed
the PedsQL
TM generic core scales parent-proxy or child
self-report questionnaire during a routine clinic visit.
HRQL was the primary outcome measured. Family income
and sickle cell disease were the primary independent
variables of interest.
Results A total of 104 children with sickle cell disease
and 74 without disease participated in the study. After
adjusting for family income, patient age, and the presence
of co-morbidities, children with severe sickle cell disease
had increased odds of worse overall HRQL (parent-proxy
HRQL report odds ratio [OR] 4.0) and physical HRQL
(parent-proxy report OR 5.67, child self-report OR 3.33)
compared to children without sickle cell disease.
Conclusions Children with sickle cell disease have sig-
niﬁcantly impaired HRQL, even after considering the
potential detrimental effect of family income on HRQL.
Targeted interventions to improve these children’s HRQL
are warranted.
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Introduction
Health-related quality of life (HRQL) is a complex patient-
reported outcome that provides an assessment of how an
illness, its complications, and its treatment affect the
patient. It has become increasingly important to measure
patient-reported outcomes such as HRQL [1] to evaluate
prognostic factors, to identify problems that can be targeted
by an intervention, to compare therapies, and to allocate
resources.
The HRQL of children with sickle cell disease is gen-
erally poor [2–4]. However, the extent to which the disease
itself impacts the HRQL of these children is not clear, since
these children are at risk for poor HRQL due to other
factors, such as low family income. In the United States,
children with sickle cell disease are largely African
American. It is well known that African American children
are more likely to live in poverty and reside in families
with lower family income in the United States [5], a risk
factor that was found to be associated with worse HRQL in
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important to assess the effect of sickle cell disease on
HRQL while acknowledging that children with sickle cell
disease are likely to be impoverished.
The objective of this study was to determine the impact
of family income and sickle cell disease on the HRQL of
children. Our hypothesis was that children with sickle cell
disease have worse HRQL than children without sickle cell
disease, even after considering the potential detrimental
effect of lower family income on HRQL.
Patients and methods
Study setting and subjects
This was a cross-sectional study conducted from January
2006 through June 2007. Two groups of children aged
2–18 years were eligible for the study: (1) children with
sickle cell disease who presented for a routine check-up at
the Midwest Sickle Cell Center (MSCC) clinic and (2)
children without sickle cell disease who presented for a
routine check-up at the Downtown Health Center in Mil-
waukee, Wisconsin. Children were excluded from the study
if they had an acute illness or were hospitalized within the
last month.
The MSCC serves over 300 children with sickle cell
disease and is based within an academic children’s hospi-
tal. The Downtown Health Center is an urban-based clinic
that provides primary care to over 4,000 children a year.
The majority of patients who regularly attend this clinic are
African American (80%) and have public insurance (34%
Medicaid, 58% Medicaid-HMO).
The demographic data were parent-reported or obtained
from the child’s medical record. Race data for the children
was collected using a modiﬁed United States Census
classiﬁcation and reﬂect parent report based on the fol-
lowing choices: White, Black, native Hawaiian or other
Paciﬁc Islander, Asian, American Indian or Alaskan native,
other or unknown.
The Institutional Review Board of the Children’s Hos-
pital of Wisconsin/Medical College of Wisconsin approved
the study. Informed consent was obtained from the parent
and assent from children 7 years of age or older.
Primary outcome
The primary outcome was HRQL measured with the
PedsQL
TM generic core scales parent-proxy and child self-
report questionnaire. The PedsQL is a 23-item generic
HRQL questionnaire that has a parent-proxy report for
children aged 2–18 years and a child self-report question-
naire for children aged 5–18 years [7]. The questionnaire
yields information on the physical, emotional, social,
and school functioning of the child during the previous
4 weeks. It has been extensively tested in healthy children
[8, 9], children with chronic disease [10–13], and was
recently validated in children with sickle cell disease by
our group [14]. Mean scores are calculated based on a ﬁve-
point response scale for each item and transformed to a
0–100 scale, with a higher score representing better quality
of life. There are four scale scores: physical functioning,
emotional functioning, social functioning, and school
functioning. In addition, the PedsQL yields three summary
scores: a total scale score, a physical health summary score,
and a psychosocial health summary score. The total score
is comprised of the average of all items in the question-
naire. The psychosocial summary score is comprised of the
average of the items in the emotional, social, and school
functioning scales. The physical health summary score is
comprised of the average of the items in the physical
functioning scale and is the same as the physical func-
tioning scale score. Missing items were handled based on
the developer’s recommendation, which allows a scale
score to be calculated if at least 50% of the items in each
scale are answered [7].
Variables
Our primary covariates of interest were family income and
the presence of sickle cell disease. However, because the
severity of sickle cell disease (deﬁned below) [4], age, and
the presence of other chronic conditions (medical and
neurobehavioral co-morbidities) [3, 4, 12, 15, 16] could
also affect HRQL, we also examined the effect of these
variables on HRQL.
Family income
The parents/primary caregivers were asked to provide their
total household income on a categorical scale for the
family income variable. For those respondents that did not
provide a family income (n = 41), the median household
income within their census block group utilizing street
addresses was used as a proxy for their income level. The
census block group was identiﬁed using the U.S. Census
Bureau’s American Fact Finder. Data from the 2000 Cen-
sus Summary File 3 were downloaded for each of the block
groups identiﬁed. Census data were merged with survey
data by block group.
Family income was then categorized into three groups
(\$20,000, $20,000–40,000, and [$40,000), based on
work done in a prior evaluation of HRQL and income [6].
We used $20,000 as our lowest category of family income,
which is consistent with the weighted average 2006 pov-
erty threshold ($20,614) for a family of four (representing
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are included, i.e., three adults and one child, one adult and
three children) [5].
Disease severity
For children with sickle cell disease, disease status was
classiﬁed a priori as mild or severe disease, regardless of
the child’s sickle cell disease type, which is consistent with
how we have classiﬁed disease severity in our prior work
[14, 17]. Children with a history of a sickle cell-related
stroke, acute chest syndrome, three or more hospitaliza-
tions for vasoocclusive painful events in the prior 3 years,
and/or recurrent priapism were classiﬁed as having severe
disease based on criteria used for intervention with
hydroxyurea or bone marrow transplantation [18–20]. All
others were classiﬁed as having mild disease. The type of
sickle cell disease (hemoglobin SS versus SC, etc.) was not
used as a marker of disease severity, as it is well known
that there is inherent variability in the phenotypic expres-
sion and disease manifestations within particular sickle cell
genotypes. Because HRQL is meant to reﬂect the well
being and functioning of individuals, it is the experience of
disease complications and morbidity in individuals that
more accurately reﬂects their disease status and the
potential impact that this will have on HRQL.
Other chronic conditions
Parents were asked to report whether they had ever been
told by a health care provider that their child had any of the
following medical conditions: asthma, chronic allergies/
sinus trouble, chronic orthopedic/bone/joint problems,
chronic rheumatic disease, diabetes, epilepsy, or other
chronic medical condition. Patients were classiﬁed as
having a medical co-morbidity if they reported one or more
of the above chronic medical conditions.
In addition, parents were asked to report whether they
had ever been told by a health care provider that their child
had any of the following neurobehavioral conditions:
anxiety, attentional or behavioral problems, depression,
developmental delay or mental retardation, learning prob-
lems, or speech problems. Patients were classiﬁed as
having a neurobehavioral co-morbidity if they reported one
or more of the above-noted neurobehavioral conditions.
Age
Age was examined using the age categories of the PedsQL
questionnaire: 2–4 years, 5–7 years, 8–12 years, and
13–18 years.
Statistical analysis
Descriptive statistics were used to compare the distribution
of demographic factors between children with and without
sickle cell disease. Continuous factors were compared
using two-sample t-tests and non-parametric Wilcoxon
rank-sum tests, where appropriate. Categorical factors were
compared using Chi-square tests and Fisher–Freeman–
Halton tests, where appropriate.
To examine the combined effects of sickle cell severity
and family income adjusted for medical co-morbidities,
neurobehavioral co-morbidities, and age on HRQL, each
scale or subscale was divided into categories of impairment
based on published population data from Varni et al. [9].
This categorization was performed because of skewed
outcome distributions in the presence of ceiling effects,
especially amongst the control population. Varni et al.
deﬁne an impaired HRQL score as less than the population
mean - 1 standard deviation (SD). Thus for each scale, the
mean and SD were used to produce four categories of
decreasing impairment: highly impaired (Bmean – 2 SD),
impaired ([mean – 2 SD but Bmean – 1 SD), average
([mean – 1 SD but Bmean), and above average ([mean).
For example, in the case of the parent-proxy report total
score, this led to cutpoints at scores of 49.50, 65.42, and
81.34 on the 100-point scale. An ordinal logistic regression
model was then ﬁtted to the scale outcome with disease
group, disease severity, family income, and the presence of
medical and neurobehavioral co-morbidities as indepen-
dent predictors. The presented odds ratios (OR) from the
ordinal logistic regression model represent the odds of
scoring lower on the ordinal scale, implying worse HRQL.
The imputation of family income based on census data
for the 41 respondents with missing income has the
potential to bias our results. Consequently, we examined
models with missing data as a separate poverty category to
test whether the missing data had any effect on the results.
Since it did not, we only present the results with the
imputed data in the results section.
Predicted probabilities of impaired HRQL (Bpopulation
mean – 1 SD) were calculated using the ﬁtted values from
the ordinal logistic regression models. All analyses were
performed using SAS v9.1.3 (SAS Inc., Cary, NC). An
alpha level of 0.05 was used throughout to denote statis-
tical signiﬁcance.
Results
Study population
We recruited a convenience sample of patients from both
clinics (Fig. 1). Thirty-three subjects with sickle cell
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having an interest in participating or stating that they did
not have time to participate. Nine children completed a
child self-report of the PedsQL but the parent did not.
Twenty subjects without sickle cell disease refused to
participate, again due to the lack of interest or not having
time for the study. Our ﬁnal sample size was 178 subjects;
104 with sickle cell disease and 74 without sickle cell
disease.
Parent and child demographics
The majority of parents in both groups were African
American, although the parents of children with sickle cell
disease were more likely to be African American compared
to the parents of children without sickle cell disease
(Table 1). In addition, parents of children without sickle
cell disease had a higher percentage of reporting the lowest
family income (Table 1). Children with sickle cell disease
had the following types of sickle cell disease: 66 hemo-
globin SS, 26 hemoglobin SC, nine hemoglobin Sb
?, one
hemoglobin Sb
0, and two other sickle cell disease variants.
Asthma was the most common medical co-morbidity
reported for children in both groups, while attentional and
behavioral problems were the most common neurobehav-
ioral co-morbidity (Table 2). The children without sickle
cell disease reported more medical co-morbidities than the
group of children with sickle cell disease (Table 2).
HRQL: parent-proxy (for children aged 2–18 years)
and child self-report (for children aged 5–18 years)
We have previously published the reliability, feasibility,
and HRQL summary and scale scores in these populations
showing very little missing data and the poor HRQL of
children with sickle cell disease compared to children
without disease [14]. Brieﬂy, based on the parent-proxy
report, children with sickle cell disease displayed signiﬁ-
cantly lower scores on all three summary scores, as well as
on the social functioning and school functioning scale
scores. In contrast, for the child self-reports, children with
sickle cell disease only reported signiﬁcantly lower scores
for the physical health summary score [14].
Children with sickle cell disease have worse HRQL
than children who do not have sickle cell disease
after accounting for family income
Parent-proxy HRQL
When the effect of sickle cell disease on HRQL was
examined taking into account other potential risk factors,
children with severe sickle cell disease had a 4.00 times
higher odds of having worse total HRQL. Family income at
the lowest income level was also indicative of having
worse total HRQL for all children (OR 2.88). Similar to our
prior work and that of others in sickle cell disease [3, 4],
having other co-morbidities and being of older age were
also associated with worse HRQL (Table 3).
When the data were further examined by looking at the
effect of these covariates on the physical HRQL summary
score, children with sickle cell disease had an increased
odds of worse physical HRQL. Likewise, having medical
co-morbidities, being of older age, and lower family
income were also associated with worse physical HRQL.
When examining psychosocial HRQL, children with
sickle cell disease had an increased odds of a worse psy-
chosocial HRQL independent of the other co-variates. In
addition, older children and having medical or neurobe-
havioral co-morbidities were associated with worse
psychosocial HRQL.
To test whether disease differentially affects HRQL
across poverty levels, we also examined models including
interaction terms for disease group and poverty level. Since
none of the interactions were signiﬁcant, the detailed
results are not shown.
Child self-report HRQL
When the child self-report of HRQL was examined for the
effect of sickle cell disease in the regression model taking
into account the other variables, children with severe sickle
cell disease had a 3.33 times increased odds of having
worse physical HRQL. Unlike in the parent-proxy report of
HRQL, none of the variables considered displayed a
signiﬁcant effect on psychosocial HRQL in the child
self-report sample (Table 4).
Fig. 1 Description of the available PedsQL parent-proxy reports and
child self-reports for children with sickle cell disease (SCD) and
control populations
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The nomogram in Fig. 2 shows the predicted probability of
an impaired physical health summary score to illustrate the
impact of all of the variables on the HRQL of children.
These probabilities, based on the ordinal regression model,
represent the probability of parent-reported physical HRQL
falling more than one SD below the population mean
reported in Varni et al. [9]. The number of points for each
condition is determined by matching the condition, e.g.,
yes on co-morbidities, to the corresponding vertical loca-
tion (50 points). For example, children with severe sickle
cell disease (100 points) who are at the lowest income level
(80 points), who are from the oldest age group (58 points),
and who have a neurobehavioral co-morbidity (17 points)
and a medical co-morbidity (50 points) represent the
highest risk group (305 points summed). Using the total
points assessed of 305 on the total points line, they would
have approximately an 80% predicted probability (bottom
line) of having an impaired physical HRQL. On the other
hand, if a child has only mild sickle cell disease (50 points)
but is from the lowest family income group (80 points), is
in the lowest age group (0 points), has no neurobehavioral
co-morbidities (0 points), and also has asthma (a medical
co-morbidity—50 points), the predicted probability (from
the total of 180 points) of having an impaired physical
HRQL is reduced to roughly 43%. It is important to note
that we have, for simplicity, omitted estimates of the
variability surrounding the predicted probabilities. As dis-
cussed by Iasonos et al. [21], it is possible that two
Table 1 Sociodemographic
characteristics of the disease
and control children
* P-value based on the
Wilcoxon rank-sum test
Variable Children with
sickle cell disease
Children without
sickle cell disease
P-value
Parent-proxy report total sample
n 104 74
–
Age (years) 0.036
2–4 27 (26.0) 26 (35.1)
5–7 14 (13.5) 15 (20.3)
8–12 26 (25.0) 21 (28.4)
13–18 37 (35.6) 12 (16.2)
Gender 0.374
Male 52 (50.0) 32 (43.2)
Race/ethnicity \0.001
African American 98 (94.2) 58 (78.4)
Other 1 (1.0) 14 (18.9)
Unreported 5 (4.8) 2 (2.7)
Disease status –
Mild disease 50 (48.1) –
Severe disease 54 (51.9) –
Parent-reported family income level 0.016
[$40,000 22 (21.2) 5 (6.8)
[$20,000 and B$40,000 26 (25.0) 13 (17.6)
B$20,000 36 (34.6) 35 (47.3)
Unknown 20 (19.2) 21 (28.4)
Median census household income
Mean ± SD 28,678 ± 1,143 27,798 ± 1,557 0.253*
Child self-report total sample
n 69 40 –
Disease status –
Mild disease 26 (37.7) –
Severe disease 43 (62.3) –
Parent-reported family income level 0.037
[$40,000 18 (26.1) 2 (5.0)
[$20,000 and B$40,000 19 (27.5) 9 (22.5)
B$20,000 21 (30.4) 16 (40.0)
Unknown 11 (15.9) 13 (32.5)
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ferential variability surrounding that estimate, depending
on the components of the risk. Therefore, if such models
are to be used as a prognostic tool for identifying children
with sickle cell disease at risk for impaired HRQL, this
variability will need to be accounted for in the future.
Discussion
The impact of sickle cell disease on the HRQL of children
is apparent, despite whether the children are living in
homes with the lowest family income. Because many of
these children do live in poverty and have other medical or
neurobehavioral co-morbidities in addition to sickle cell
disease, the impact of sickle cell disease on HRQL is even
more severe. There are no similar chronic diseases that
primarily affect those from an impoverished, minority
background and our ﬁndings highlight how this uniquely
affects children with sickle cell disease.
Our study is the ﬁrst that we know of to examine the
collective effect of family income and disease severity on
the HRQL of children with sickle cell disease. Other
markers of income, such as education of the parent and
work status, have been examined and are found to have
conﬂicting results on HRQL in children with sickle cell
disease [3, 4]. However, this prior work has shown the
negative effect that disease severity has on the HRQL of
the child with sickle cell disease [3, 4, 17]. Because sickle
cell disease predominately affects African Americans who
are likely to have lower family income [5], it was important
to examine the impact of sickle cell disease and family
income on the HRQL of these children. Although our
Table 2 Medical and neurobehavioral co-morbidities of disease and
control children
Sickle cell
disease
(n = 104)
Controls
(n = 74)
P-value
Medical co-morbidities
Any 27 (26.0) 35 (47.3) 0.003
Asthma 20 (19.2) 28 (37.8)
Chronic allergies 6 (5.8) 11 (14.9)
Diabetes 1 (1.0) 1 (1.4)
Chronic orthopedic, bone, or
joint problems
9 (8.7) 3 (4.1)
Epilepsy 4 (3.9) 1 (1.4)
Rheumatic disease 1 (1.0) 0 (0.0)
Other 2 (1.9) 5 (6.8)
Neurobehavioral co-morbidities
Any 42 (40.4) 35 (47.3) 0.359
Anxiety problems 6 (5.8) 9 (12.2)
Attentional problems 24 (23.1) 18 (24.3)
Behavioral problems 20 (19.2) 18 (24.3)
Depression 8 (7.7) 6 (8.1)
Developmental delay or mental
retardation
4 (3.9) 7 (9.5)
Learning problems 21 (20.1) 14 (18.9)
Speech problems 10 (9.6) 10 (13.5)
Table 3 Ordinal logistic regression for PedsQL parent-proxy report
Outcome Total score Physical health Psychosocial health
OR* 95% CI OR* 95% CI OR* 95% CI
Age (years)
2–4 (referent) – – – – – –
5–7 1.85 (0.75, 4.75) 1.69 (0.68, 4.19) 1.51 (0.62, 3.69)
8–12 2.61 (1.19, 5.75) 2.55 (1.13, 5.76) 2.63 (1.18, 5.84)
13–18 2.74 (1.19, 6.29) 2.70 (1.13, 6.44) 2.42 (1.05, 5.57)
Sickle cell disease
No disease (referent) – – – – – –
Mild sickle cell disease 2.11 (1.00, 4.43) 2.26 (1.05, 4.87) 2.27 (1.08, 4.78)
Severe sickle cell disease 4.00 (1.92, 8.31) 5.67 (2.68, 11.97) 2.81 (1.37, 5.77)
Family income
[$40,000 (referent) – – – – – –
[$20,000 and B$40,000 1.69 (0.72, 3.96) 2.78 (1.16, 6.65) 1.37 (0.59, 3.19)
B$20,000 2.88 (1.22, 6.79) 3.87 (1.62, 9.26) 2.20 (0.94, 5.15)
Medical co-morbidity 2.30 (1.25, 4.24) 2.39 (1.28, 4.47) 3.04 (1.62, 5.70)
Neurobehavioral co-morbidity 1.95 (1.07, 3.57) 1.34 (0.73, 2.46) 2.31 (1.25, 4.27)
OR odds ratio, CI conﬁdence interval
* The odds ratios denote the odds of scoring lower on the ordinal scale, i.e., the odds of having worse HRQL
Bold denotes statistical signiﬁcance
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with sickle cell disease, we still demonstrated a signiﬁcant
effect of family income on the HRQL of children with
sickle cell disease.
Prior work has demonstrated the negative impact of
lower socioeconomic status on the HRQL of healthy school
children [6, 8, 22, 23]. In addition, there has been some
work examining the impact of markers of socioeconomic
status on the HRQL of children with chronic disease
[9, 23–25]. In children with asthma, lower income was a
signiﬁcant, independent predictor of worse HRQL, whereas
disease severity was not [24]. Our study found similar
results regarding income, but also found the signiﬁcant
impact that sickle cell disease has on the HRQL of these
children.
In addition to the impact of poverty, many of the chil-
dren with sickle cell disease have another co-morbidity,
such as asthma or attentional problems, which also affects
their well being. The additional challenges of poverty and
having other chronic conditions need to be considered in
the context of care for these children. As health care pro-
viders caring for these children, we have very limited
ability to improve their family income. However, future
research to determine how treatment for co-morbidities and
improvement in disease status affect well being, especially
physical well being, are needed as health care providers are
able to provide therapy that improves disease status for
medical co-morbidities and sickle cell disease.
We did not see the same signiﬁcant results from the
regression models for the parent-proxy and child-self-
reports. This may largely be a function of the decreased
sample size of child-reports. The point estimates of the
odds ratios from each model display the same relationship
across both parent-proxy and child-self-reports. However,
some degree of disagreement between parent and child
reports is not an unexpected result, as there has been
consistent evidence indicating that proxy reports of HRQL
Table 4 Ordinal logistic regression for PedsQL child-self-report
Outcome Total score Physical health Psychosocial health
OR* 95% CI OR* 95% CI OR* 95% CI
Age (years)
5–7 (referent) – – – – – –
8–12 0.41 (0.16, 1.03) 0.63 (0.25, 1.60) 0.41 (0.15, 1.07)
13–18 0.43 (0.17, 1.12) 0.60 (0.23, 1.53) 0.38 (0.15, 1.00)
Sickle cell disease
No disease (referent) – – – – – –
Mild sickle cell disease 1.99 (0.77, 5.15) 2.59 (0.98, 6.84) 1.15 (0.42, 3.14)
Severe sickle cell disease 2.18 (0.95, 4.99) 3.33 (1.39, 7.99) 1.80 (0.78, 4.18)
Income level
[$40,000 (referent) – – – – – –
[$20,000 and B$40,000 2.07 (0.74, 5.78) 1.70 (0.60, 4.78) 1.95 (0.68, 5.59)
B$20,000 2.01 (0.72, 5.64) 1.62 (0.58, 4.54) 1.54 (0.53, 4.53)
Medical co-morbidity 1.58 (0.77, 3.25) 1.19 (0.57, 2.49) 1.73 (0.82, 3.65)
Neurobehavioral co-morbidity 1.52 (0.75, 3.09) 1.24 (0.60, 2.56) 1.39 (0.68, 2.83)
Results based on n = 109; see Fig. 1
OR odds ratio, CI conﬁdence interval
* The odds ratios denote the odds of scoring lower on the ordinal HRQL scale, i.e., the odds of having worse HRQL
Bold denotes statistical signiﬁcance
Fig. 2 Nomogram for the predicted probability (which denotes the
probability that physical health-related quality of life (HRQL) is B1
SD below the population mean reported by Varni et al. [9]) of
impaired physical HRQL: parent-proxy report
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26, 27]. Two prior studies in children with asthma that
utilized child self-report of disease-speciﬁc HRQL (but no
parent-proxy report of HRQL) found lower socioeconomic
status [25] and lower household income [24] to be associ-
ated with worse HRQL in children. There are a few prior
studies that have utilized both a parent and child self-report
of generic HRQL [8, 23] and examined the impact of
socioeconomic factors. One study using a generic HRQL
tool found that chronic disease and a family’s ﬁnancial
situation were associated with parent-proxy report of the
child’s HRQL [23]. However, this study did not ﬁnd an
effect of chronic disease on HRQL in the child self-report
but did ﬁnd an association with the child self-report of
HRQL and the family’s ﬁnancial situation [23]. Another
study, using the generic PedsQL parent-proxy and child
self-reports, found that children with chronic disease had
worse HRQL compared to healthy children when socio-
economic status was controlledfor in their analysis [8]. This
study did not examine the independent effects of both
chronic disease and socioeconomic status together. Fur-
thermore, the lack of a disease-speciﬁc tool may have
prevented us from detecting the impact of disease and
family income on the child self-report of HRQL in children
with sickle cell disease. In the study by Van Dellen et al.
[25] examining asthma, there were no signiﬁcant associa-
tions found between socioeconomic status and generic
HRQL, even though, as noted above, they found differences
in HRQL by household income when using the disease-
speciﬁc asthma measure of HRQL. This study did not report
parent-proxy HRQL data. Future research will need to
investigate whether disease and poverty do, somehow,
differentially affect a child’s perception of their HRQL.
Other limitations of our study are its cross-sectional
design and that it does not take into account family income
over time. Other measures of socioeconomic status were
not assessed, such as material deprivation, which may also
impact a child’s HRQL. In addition, not all families
reported their total family income, so census block group
data was used to estimate their family income. The census
block group data were obtained by utilizing the street
address of both groups of children. This method of deter-
mining family income has been shown to be valid [28, 29].
Additionally, since the census income did not differ sig-
niﬁcantly between groups, this should be a reasonable
estimate of family income for those families who did not
self-report the data. However, because we have more
missing data on family income within our control popula-
tion, our family income data may be biased and may have
led to an over or under estimation of the effect of family
income. Lastly, we drew our study population from a
convenience sample, which may have biased our results
and made them less generalizable to other populations.
Conclusions
In conclusion, children with sickle cell disease have worse
health-related quality of life (HRQL) compared to children
without sickle cell disease after adjusting for income level
and other signiﬁcant covariates. Older children with severe
sickle cell disease who have the lowest family income and
other co-morbidities have the worst HRQL.
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